Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2

7.1K views

Cited by 6

08:52 min

March 10th, 2016

10.3791/53919-v

March 10th, 2016

7.1K views

Generating cardiomyocytes from pluripotent stem cells in vitro allows access to large amounts of cardiac tissue in vitro for basic science and clinical applications. This protocol uses the atrializing factor Grem2 to both increase the numbers of cardiomyocytes obtained and to generate cardiomyocytes with an atrial phenotype.

Explore More Videos

Atrial Cardiomyocytes

Chapters in this video

0:05

Title

0:33

Murine Embryonic Stem Cell (mESC) Culture and Passaging

3:16

Embryoid Body (EB) Preparation and Grem2 Treatment

6:12

Results: Grem2-induction of Cardiomyocyte Differentiation

8:00

Conclusion

Related Videos